General MedicationsORALStandard
SEVELAMER CARBONATE
SEVELAMER CARBONATE
Standard Dose
800MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview SEVELAMER CARBONATE is listed in Drugs@FDA under application 219931 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient SEVELAMER CARBONATE Form and strength TABLET;ORAL - 800MG Sponsor NAVINTA LLC Submission history Latest submission status date: 2025-10-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview SEVELAMER CARBONATE is listed in Drugs@FDA under application 219931 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SEVELAMER CARBONATE Form and strength TABLET;ORAL - 800MG Sponsor NAVINTA LLC Submission history Latest submission status date: 2025-10-27 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.